Ranolazine dihydrochloride
CAS No. 95635-56-6
Ranolazine dihydrochloride( RS-43285 )
Catalog No. M16826 CAS No. 95635-56-6
An anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 40 | In Stock |
|
100MG | 56 | In Stock |
|
200MG | 87 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRanolazine dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.
-
DescriptionAn anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models; also inhibits cardiac sodium channel Nav1.5, shows antiarrhythmic, antiepileptic, and analgesic effects.Other Indication Approved(In Vivo):Ranolazine (Bolus injection 10 mg/kg and infusion 9.6 mg/kg/h; bolus injection; for 145 minutes; male Wistar rats) treatment significantly reduces infarct size and cardiac troponin T release in rats subjected to left anterior descending coronary artery occlusion-reperfusion.
-
In Vitro——
-
In VivoRanolazine (Bolus injection 10 mg/kg and infusion 9.6 mg/kg/h; bolus injection; for 145 minutes; male Wistar rats) treatment significantly reduces infarct size and cardiac troponin T release in rats subjected to left anterior descending coronary artery occlusion-reperfusion. Animal Model:Male Wistar rats (240-350 g) Dosage:Bolus injection 10 mg/kg and infusion (9.6 mg/kg/h) Administration:Bolus injection; for 145 minutes Result: Significantly reduced infarct size and cardiac troponin T release in rats subjected to left anterior descending coronary artery occlusion-reperfusion.
-
SynonymsRS-43285
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorCalciumChannel|SodiumChannel
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number95635-56-6
-
Formula Weight500.4584
-
Molecular FormulaC24H35Cl2N3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCl.Cl.COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
-
Chemical Name1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, hydrochloride (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sokolov S, et al. Front Pharmacol. 2013 Jun 21;4:78.
2. Noble D, et al. Heart. 2006 Jul;92 Suppl 4:iv1-iv5.
3. Wang WQ, et al. J Pharmacol Exp Ther. 2008 Jun;325(3):875-81.
molnova catalog
related products
-
Pramoxine hydrochlor...
Pramocaine hydrochloride is a topical anesthetic, and used as an antipruritic.
-
7-O-Methylmangiferin
7-O-MethylMangiferin is an xanthone isolated from the rhizomes of Iris nigricans.
-
Benzonatate
Benzonatate is an antagonist of sodium channel protein.Na(+) currents are inhibited most potently by a benzonatate fraction containing the 9-ethoxy component.?